Lung cancer remains one of the malignancies with the highest incidence and mortality worldwide. Clinical practice has long been plagued by core dilemmas, including insufficient sensitivity in early ...

The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine. Diagnosing kidney cancer ...

LisenID uses a biomarker called loss of imprinting to apply to ambiguous biopsy results and return a diagnosis of lung cancer.

Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most artificial intelligence (AI) tools rely on dermoscopic images alone, they ...

This review explores how multi-source data-driven machine learning is transforming lung cancer care, from early screening and ...

Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...

Forbes contributors publish independent expert analyses and insights. Sai writes about healthcare, innovation and technology. This voice experience is generated by AI. Learn more. This voice ...

The U.S. market is projected to reach USD 639.13 Million by 2035 from USD 357.90 Million in 2025, while Europe remains a key regional market driven by AI adoption and cancer screening.Austin, United ...